Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Company files 510(k) application with U.S. FDA on microendoscope for breast exams
December 22nd, 2005
Lifeline Biotechnologies (LBTN) announced that the company has filed a 510(k) pre-market notification with the U.S. Food & Drug Administration (FDA), for the MastaScope product line. The MastaScope is a microendoscope that is utilized by physicians to observe the interior of women's breast milk ducts when examining for abnormalities, in particular, nipple discharge. The majority of breast cancers originate in the milk ducts. It is anticipated that this product and process of examination, will assist in the early detection of breast cancer and holds the prospect of reducing unnecessary exploratory surgeries. Lifeline's technologies...
Source: Women's Health Weekly (2005-12-22)
|
